Xiansheng Pharmaceutical announced that on November 14, 2026, Xianbixin® sublingual tablets have been officially included in the “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue” issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security, and will take effect from January 1, 2027. Furthermore, Xianbixin® Injection successfully completed the third medical insurance renewal.

Zhitongcaijing · 1d ago
Xiansheng Pharmaceutical announced that on November 14, 2026, Xianbixin® sublingual tablets have been officially included in the “National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue” issued by the National Health Insurance Administration and the Ministry of Human Resources and Social Security, and will take effect from January 1, 2027. Furthermore, Xianbixin® Injection successfully completed the third medical insurance renewal.